nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C19—prostate cancer	0.245	1	CbGaD
Moclobemide—CYP2C19—Bicalutamide—prostate cancer	0.0449	0.0999	CbGbCtD
Moclobemide—CYP2C19—Nilutamide—prostate cancer	0.0449	0.0999	CbGbCtD
Moclobemide—CYP2C9—Nilutamide—prostate cancer	0.0373	0.0831	CbGbCtD
Moclobemide—CYP2C9—Bicalutamide—prostate cancer	0.0373	0.0831	CbGbCtD
Moclobemide—CYP2C19—Flutamide—prostate cancer	0.0372	0.0828	CbGbCtD
Moclobemide—CYP1A2—Flutamide—prostate cancer	0.0343	0.0764	CbGbCtD
Moclobemide—CYP2D6—Bicalutamide—prostate cancer	0.0341	0.076	CbGbCtD
Moclobemide—CYP2D6—Abiraterone—prostate cancer	0.0283	0.063	CbGbCtD
Moclobemide—CYP1A2—Estrone—prostate cancer	0.0248	0.0552	CbGbCtD
Moclobemide—CYP2C9—Estrone—prostate cancer	0.0224	0.0498	CbGbCtD
Moclobemide—CYP2C9—Capecitabine—prostate cancer	0.0169	0.0377	CbGbCtD
Moclobemide—CYP1A2—Conjugated Estrogens—prostate cancer	0.0162	0.0361	CbGbCtD
Moclobemide—CYP2C19—Estradiol—prostate cancer	0.0154	0.0344	CbGbCtD
Moclobemide—CYP1A2—Estradiol—prostate cancer	0.0142	0.0317	CbGbCtD
Moclobemide—CYP2C19—Prednisone—prostate cancer	0.0133	0.0296	CbGbCtD
Moclobemide—CYP2C9—Estradiol—prostate cancer	0.0128	0.0286	CbGbCtD
Moclobemide—CYP1A2—Etoposide—prostate cancer	0.0093	0.0207	CbGbCtD
Moclobemide—CYP2D6—Doxorubicin—prostate cancer	0.00523	0.0116	CbGbCtD
Moclobemide—CYP2C19—urine—prostate cancer	0.00303	0.151	CbGeAlD
Moclobemide—CYP1A2—urine—prostate cancer	0.00247	0.123	CbGeAlD
Moclobemide—CYP2C9—urine—prostate cancer	0.00235	0.117	CbGeAlD
Moclobemide—CYP2D6—urine—prostate cancer	0.00176	0.0878	CbGeAlD
Moclobemide—MAOB—prostate gland—prostate cancer	0.00125	0.0621	CbGeAlD
Moclobemide—Haloperidol—CBR1—prostate cancer	0.00112	0.226	CrCbGaD
Moclobemide—MAOA—prostate gland—prostate cancer	0.00106	0.053	CbGeAlD
Moclobemide—MAOB—seminal vesicle—prostate cancer	0.00106	0.0526	CbGeAlD
Moclobemide—MAOA—seminal vesicle—prostate cancer	0.0009	0.0448	CbGeAlD
Moclobemide—MAOB—renal system—prostate cancer	0.00085	0.0424	CbGeAlD
Moclobemide—MAOB—urethra—prostate cancer	0.000835	0.0416	CbGeAlD
Moclobemide—MAOA—renal system—prostate cancer	0.000725	0.0361	CbGeAlD
Moclobemide—MAOA—urethra—prostate cancer	0.000713	0.0355	CbGeAlD
Moclobemide—Minaprine—ACHE—prostate cancer	0.000705	0.142	CrCbGaD
Moclobemide—Bezafibrate—PPARA—prostate cancer	0.000689	0.139	CrCbGaD
Moclobemide—CYP1A2—renal system—prostate cancer	0.000605	0.0302	CbGeAlD
Moclobemide—MAOB—testis—prostate cancer	0.00055	0.0274	CbGeAlD
Moclobemide—Procainamide—DNMT1—prostate cancer	0.000547	0.11	CrCbGaD
Moclobemide—MAOA—testis—prostate cancer	0.000469	0.0234	CbGeAlD
Moclobemide—CYP2D6—renal system—prostate cancer	0.000431	0.0215	CbGeAlD
Moclobemide—MAOB—lymph node—prostate cancer	0.000398	0.0198	CbGeAlD
Moclobemide—Procainamide—SLC22A3—prostate cancer	0.000358	0.0721	CrCbGaD
Moclobemide—MAOA—lymph node—prostate cancer	0.00034	0.0169	CbGeAlD
Moclobemide—Procainamide—ACHE—prostate cancer	0.000324	0.0652	CrCbGaD
Moclobemide—CYP2D6—testis—prostate cancer	0.000279	0.0139	CbGeAlD
Moclobemide—Procainamide—SLC22A1—prostate cancer	0.000256	0.0517	CrCbGaD
Moclobemide—Bezafibrate—CYP1A1—prostate cancer	0.000223	0.0449	CrCbGaD
Moclobemide—Haloperidol—CYP3A5—prostate cancer	0.000213	0.043	CrCbGaD
Moclobemide—Haloperidol—CYP2C19—prostate cancer	0.000145	0.0292	CrCbGaD
Moclobemide—Haloperidol—CYP1A1—prostate cancer	0.000145	0.0291	CrCbGaD
Moclobemide—Bezafibrate—CYP3A4—prostate cancer	0.000142	0.0287	CrCbGaD
Moclobemide—Flushing—Prednisone—prostate cancer	9.54e-05	0.000591	CcSEcCtD
Moclobemide—Hypotension—Etoposide—prostate cancer	9.52e-05	0.000589	CcSEcCtD
Moclobemide—Gastritis—Doxorubicin—prostate cancer	9.51e-05	0.000589	CcSEcCtD
Moclobemide—Vision blurred—Capecitabine—prostate cancer	9.46e-05	0.000586	CcSEcCtD
Moclobemide—Asthenia—Estradiol—prostate cancer	9.43e-05	0.000584	CcSEcCtD
Moclobemide—Tremor—Capecitabine—prostate cancer	9.41e-05	0.000583	CcSEcCtD
Moclobemide—Dysuria—Epirubicin—prostate cancer	9.39e-05	0.000581	CcSEcCtD
Moclobemide—Abdominal distension—Doxorubicin—prostate cancer	9.35e-05	0.000579	CcSEcCtD
Moclobemide—Ill-defined disorder—Capecitabine—prostate cancer	9.32e-05	0.000577	CcSEcCtD
Moclobemide—Syncope—Docetaxel—prostate cancer	9.3e-05	0.000576	CcSEcCtD
Moclobemide—Pruritus—Estradiol—prostate cancer	9.3e-05	0.000576	CcSEcCtD
Moclobemide—Haloperidol—CYP3A4—prostate cancer	9.23e-05	0.0186	CrCbGaD
Moclobemide—Palpitations—Docetaxel—prostate cancer	9.17e-05	0.000568	CcSEcCtD
Moclobemide—Paraesthesia—Etoposide—prostate cancer	9.15e-05	0.000566	CcSEcCtD
Moclobemide—Loss of consciousness—Docetaxel—prostate cancer	9.12e-05	0.000564	CcSEcCtD
Moclobemide—Dyspnoea—Etoposide—prostate cancer	9.08e-05	0.000562	CcSEcCtD
Moclobemide—Malaise—Capecitabine—prostate cancer	9.06e-05	0.000561	CcSEcCtD
Moclobemide—Somnolence—Etoposide—prostate cancer	9.06e-05	0.000561	CcSEcCtD
Moclobemide—Angina pectoris—Doxorubicin—prostate cancer	9.05e-05	0.00056	CcSEcCtD
Moclobemide—Syncope—Capecitabine—prostate cancer	9.01e-05	0.000558	CcSEcCtD
Moclobemide—Diarrhoea—Estradiol—prostate cancer	8.99e-05	0.000557	CcSEcCtD
Moclobemide—Hypertension—Docetaxel—prostate cancer	8.96e-05	0.000554	CcSEcCtD
Moclobemide—Drowsiness—Epirubicin—prostate cancer	8.95e-05	0.000554	CcSEcCtD
Moclobemide—Palpitations—Capecitabine—prostate cancer	8.87e-05	0.00055	CcSEcCtD
Moclobemide—Decreased appetite—Etoposide—prostate cancer	8.85e-05	0.000548	CcSEcCtD
Moclobemide—Chest pain—Docetaxel—prostate cancer	8.83e-05	0.000547	CcSEcCtD
Moclobemide—Myalgia—Docetaxel—prostate cancer	8.83e-05	0.000547	CcSEcCtD
Moclobemide—Loss of consciousness—Capecitabine—prostate cancer	8.83e-05	0.000547	CcSEcCtD
Moclobemide—Asthenia—Mitoxantrone—prostate cancer	8.79e-05	0.000544	CcSEcCtD
Moclobemide—Fatigue—Etoposide—prostate cancer	8.78e-05	0.000544	CcSEcCtD
Moclobemide—Stomatitis—Epirubicin—prostate cancer	8.73e-05	0.00054	CcSEcCtD
Moclobemide—Constipation—Etoposide—prostate cancer	8.71e-05	0.000539	CcSEcCtD
Moclobemide—Conjunctivitis—Epirubicin—prostate cancer	8.7e-05	0.000539	CcSEcCtD
Moclobemide—Dizziness—Estradiol—prostate cancer	8.69e-05	0.000538	CcSEcCtD
Moclobemide—Dysuria—Doxorubicin—prostate cancer	8.69e-05	0.000538	CcSEcCtD
Moclobemide—Hypertension—Capecitabine—prostate cancer	8.67e-05	0.000537	CcSEcCtD
Moclobemide—Dry mouth—Docetaxel—prostate cancer	8.64e-05	0.000535	CcSEcCtD
Moclobemide—Sweating—Epirubicin—prostate cancer	8.58e-05	0.000531	CcSEcCtD
Moclobemide—Chest pain—Capecitabine—prostate cancer	8.55e-05	0.000529	CcSEcCtD
Moclobemide—Myalgia—Capecitabine—prostate cancer	8.55e-05	0.000529	CcSEcCtD
Moclobemide—Confusional state—Docetaxel—prostate cancer	8.54e-05	0.000529	CcSEcCtD
Moclobemide—Anxiety—Capecitabine—prostate cancer	8.52e-05	0.000528	CcSEcCtD
Moclobemide—Discomfort—Capecitabine—prostate cancer	8.45e-05	0.000523	CcSEcCtD
Moclobemide—Vision blurred—Prednisone—prostate cancer	8.43e-05	0.000522	CcSEcCtD
Moclobemide—Feeling abnormal—Etoposide—prostate cancer	8.39e-05	0.00052	CcSEcCtD
Moclobemide—Diarrhoea—Mitoxantrone—prostate cancer	8.38e-05	0.000519	CcSEcCtD
Moclobemide—Dry mouth—Capecitabine—prostate cancer	8.36e-05	0.000518	CcSEcCtD
Moclobemide—Vomiting—Estradiol—prostate cancer	8.36e-05	0.000517	CcSEcCtD
Moclobemide—Gastrointestinal pain—Etoposide—prostate cancer	8.33e-05	0.000516	CcSEcCtD
Moclobemide—Shock—Docetaxel—prostate cancer	8.33e-05	0.000516	CcSEcCtD
Moclobemide—Ill-defined disorder—Prednisone—prostate cancer	8.3e-05	0.000514	CcSEcCtD
Moclobemide—Rash—Estradiol—prostate cancer	8.29e-05	0.000513	CcSEcCtD
Moclobemide—Drowsiness—Doxorubicin—prostate cancer	8.28e-05	0.000513	CcSEcCtD
Moclobemide—Dermatitis—Estradiol—prostate cancer	8.28e-05	0.000513	CcSEcCtD
Moclobemide—Confusional state—Capecitabine—prostate cancer	8.26e-05	0.000512	CcSEcCtD
Moclobemide—Tachycardia—Docetaxel—prostate cancer	8.26e-05	0.000512	CcSEcCtD
Moclobemide—Headache—Estradiol—prostate cancer	8.23e-05	0.00051	CcSEcCtD
Moclobemide—Agitation—Prednisone—prostate cancer	8.22e-05	0.000509	CcSEcCtD
Moclobemide—Bradycardia—Epirubicin—prostate cancer	8.18e-05	0.000507	CcSEcCtD
Moclobemide—Urticaria—Etoposide—prostate cancer	8.09e-05	0.000501	CcSEcCtD
Moclobemide—Stomatitis—Doxorubicin—prostate cancer	8.07e-05	0.0005	CcSEcCtD
Moclobemide—Malaise—Prednisone—prostate cancer	8.07e-05	0.000499	CcSEcCtD
Moclobemide—Shock—Capecitabine—prostate cancer	8.06e-05	0.000499	CcSEcCtD
Moclobemide—Abdominal pain—Etoposide—prostate cancer	8.05e-05	0.000499	CcSEcCtD
Moclobemide—Conjunctivitis—Doxorubicin—prostate cancer	8.05e-05	0.000499	CcSEcCtD
Moclobemide—Syncope—Prednisone—prostate cancer	8.02e-05	0.000497	CcSEcCtD
Moclobemide—Tachycardia—Capecitabine—prostate cancer	8e-05	0.000495	CcSEcCtD
Moclobemide—Sweating—Doxorubicin—prostate cancer	7.94e-05	0.000492	CcSEcCtD
Moclobemide—Hyperhidrosis—Capecitabine—prostate cancer	7.92e-05	0.000491	CcSEcCtD
Moclobemide—Hypotension—Docetaxel—prostate cancer	7.91e-05	0.00049	CcSEcCtD
Moclobemide—Loss of consciousness—Prednisone—prostate cancer	7.86e-05	0.000487	CcSEcCtD
Moclobemide—Nausea—Estradiol—prostate cancer	7.81e-05	0.000483	CcSEcCtD
Moclobemide—Vomiting—Mitoxantrone—prostate cancer	7.79e-05	0.000482	CcSEcCtD
Moclobemide—Visual impairment—Epirubicin—prostate cancer	7.74e-05	0.00048	CcSEcCtD
Moclobemide—Hypertension—Prednisone—prostate cancer	7.72e-05	0.000478	CcSEcCtD
Moclobemide—Rash—Mitoxantrone—prostate cancer	7.72e-05	0.000478	CcSEcCtD
Moclobemide—Dermatitis—Mitoxantrone—prostate cancer	7.71e-05	0.000478	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Docetaxel—prostate cancer	7.71e-05	0.000478	CcSEcCtD
Moclobemide—Headache—Mitoxantrone—prostate cancer	7.67e-05	0.000475	CcSEcCtD
Moclobemide—Hypotension—Capecitabine—prostate cancer	7.66e-05	0.000474	CcSEcCtD
Moclobemide—Insomnia—Docetaxel—prostate cancer	7.66e-05	0.000474	CcSEcCtD
Moclobemide—Myalgia—Prednisone—prostate cancer	7.62e-05	0.000472	CcSEcCtD
Moclobemide—Paraesthesia—Docetaxel—prostate cancer	7.6e-05	0.000471	CcSEcCtD
Moclobemide—Anxiety—Prednisone—prostate cancer	7.59e-05	0.00047	CcSEcCtD
Moclobemide—Bradycardia—Doxorubicin—prostate cancer	7.57e-05	0.000469	CcSEcCtD
Moclobemide—Dyspnoea—Docetaxel—prostate cancer	7.55e-05	0.000467	CcSEcCtD
Moclobemide—Somnolence—Docetaxel—prostate cancer	7.53e-05	0.000466	CcSEcCtD
Moclobemide—Discomfort—Prednisone—prostate cancer	7.52e-05	0.000466	CcSEcCtD
Moclobemide—Tinnitus—Epirubicin—prostate cancer	7.49e-05	0.000464	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.47e-05	0.000462	CcSEcCtD
Moclobemide—Flushing—Epirubicin—prostate cancer	7.46e-05	0.000462	CcSEcCtD
Moclobemide—Dyspepsia—Docetaxel—prostate cancer	7.45e-05	0.000461	CcSEcCtD
Moclobemide—Insomnia—Capecitabine—prostate cancer	7.41e-05	0.000459	CcSEcCtD
Moclobemide—Paraesthesia—Capecitabine—prostate cancer	7.36e-05	0.000456	CcSEcCtD
Moclobemide—Decreased appetite—Docetaxel—prostate cancer	7.36e-05	0.000456	CcSEcCtD
Moclobemide—Asthenia—Etoposide—prostate cancer	7.31e-05	0.000453	CcSEcCtD
Moclobemide—Dyspnoea—Capecitabine—prostate cancer	7.31e-05	0.000452	CcSEcCtD
Moclobemide—Fatigue—Docetaxel—prostate cancer	7.3e-05	0.000452	CcSEcCtD
Moclobemide—Nausea—Mitoxantrone—prostate cancer	7.27e-05	0.00045	CcSEcCtD
Moclobemide—Constipation—Docetaxel—prostate cancer	7.24e-05	0.000448	CcSEcCtD
Moclobemide—Dyspepsia—Capecitabine—prostate cancer	7.21e-05	0.000447	CcSEcCtD
Moclobemide—Pruritus—Etoposide—prostate cancer	7.21e-05	0.000446	CcSEcCtD
Moclobemide—Shock—Prednisone—prostate cancer	7.18e-05	0.000445	CcSEcCtD
Moclobemide—Visual impairment—Doxorubicin—prostate cancer	7.17e-05	0.000444	CcSEcCtD
Moclobemide—Tachycardia—Prednisone—prostate cancer	7.13e-05	0.000441	CcSEcCtD
Moclobemide—Decreased appetite—Capecitabine—prostate cancer	7.12e-05	0.000441	CcSEcCtD
Moclobemide—Fatigue—Capecitabine—prostate cancer	7.07e-05	0.000438	CcSEcCtD
Moclobemide—Hyperhidrosis—Prednisone—prostate cancer	7.06e-05	0.000437	CcSEcCtD
Moclobemide—Constipation—Capecitabine—prostate cancer	7.01e-05	0.000434	CcSEcCtD
Moclobemide—Feeling abnormal—Docetaxel—prostate cancer	6.98e-05	0.000432	CcSEcCtD
Moclobemide—Diarrhoea—Etoposide—prostate cancer	6.97e-05	0.000432	CcSEcCtD
Moclobemide—Tinnitus—Doxorubicin—prostate cancer	6.93e-05	0.000429	CcSEcCtD
Moclobemide—Gastrointestinal pain—Docetaxel—prostate cancer	6.92e-05	0.000429	CcSEcCtD
Moclobemide—Flushing—Doxorubicin—prostate cancer	6.9e-05	0.000427	CcSEcCtD
Moclobemide—Flatulence—Epirubicin—prostate cancer	6.89e-05	0.000427	CcSEcCtD
Moclobemide—Tension—Epirubicin—prostate cancer	6.87e-05	0.000425	CcSEcCtD
Moclobemide—Dysgeusia—Epirubicin—prostate cancer	6.85e-05	0.000424	CcSEcCtD
Moclobemide—Nervousness—Epirubicin—prostate cancer	6.79e-05	0.000421	CcSEcCtD
Moclobemide—Feeling abnormal—Capecitabine—prostate cancer	6.75e-05	0.000418	CcSEcCtD
Moclobemide—Dizziness—Etoposide—prostate cancer	6.74e-05	0.000417	CcSEcCtD
Moclobemide—Gastrointestinal pain—Capecitabine—prostate cancer	6.7e-05	0.000415	CcSEcCtD
Moclobemide—Abdominal pain—Docetaxel—prostate cancer	6.69e-05	0.000414	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Prednisone—prostate cancer	6.65e-05	0.000412	CcSEcCtD
Moclobemide—Insomnia—Prednisone—prostate cancer	6.6e-05	0.000409	CcSEcCtD
Moclobemide—Vision blurred—Epirubicin—prostate cancer	6.59e-05	0.000408	CcSEcCtD
Moclobemide—Paraesthesia—Prednisone—prostate cancer	6.56e-05	0.000406	CcSEcCtD
Moclobemide—Urticaria—Capecitabine—prostate cancer	6.51e-05	0.000403	CcSEcCtD
Moclobemide—Ill-defined disorder—Epirubicin—prostate cancer	6.49e-05	0.000402	CcSEcCtD
Moclobemide—Abdominal pain—Capecitabine—prostate cancer	6.48e-05	0.000401	CcSEcCtD
Moclobemide—Vomiting—Etoposide—prostate cancer	6.48e-05	0.000401	CcSEcCtD
Moclobemide—Agitation—Epirubicin—prostate cancer	6.43e-05	0.000398	CcSEcCtD
Moclobemide—Dyspepsia—Prednisone—prostate cancer	6.43e-05	0.000398	CcSEcCtD
Moclobemide—Rash—Etoposide—prostate cancer	6.42e-05	0.000398	CcSEcCtD
Moclobemide—Dermatitis—Etoposide—prostate cancer	6.42e-05	0.000397	CcSEcCtD
Moclobemide—Headache—Etoposide—prostate cancer	6.38e-05	0.000395	CcSEcCtD
Moclobemide—Flatulence—Doxorubicin—prostate cancer	6.38e-05	0.000395	CcSEcCtD
Moclobemide—Tension—Doxorubicin—prostate cancer	6.35e-05	0.000393	CcSEcCtD
Moclobemide—Decreased appetite—Prednisone—prostate cancer	6.35e-05	0.000393	CcSEcCtD
Moclobemide—Dysgeusia—Doxorubicin—prostate cancer	6.34e-05	0.000393	CcSEcCtD
Moclobemide—Malaise—Epirubicin—prostate cancer	6.31e-05	0.000391	CcSEcCtD
Moclobemide—Fatigue—Prednisone—prostate cancer	6.29e-05	0.00039	CcSEcCtD
Moclobemide—Nervousness—Doxorubicin—prostate cancer	6.29e-05	0.000389	CcSEcCtD
Moclobemide—Syncope—Epirubicin—prostate cancer	6.27e-05	0.000388	CcSEcCtD
Moclobemide—Constipation—Prednisone—prostate cancer	6.24e-05	0.000387	CcSEcCtD
Moclobemide—Palpitations—Epirubicin—prostate cancer	6.18e-05	0.000383	CcSEcCtD
Moclobemide—Loss of consciousness—Epirubicin—prostate cancer	6.15e-05	0.000381	CcSEcCtD
Moclobemide—Vision blurred—Doxorubicin—prostate cancer	6.1e-05	0.000378	CcSEcCtD
Moclobemide—Asthenia—Docetaxel—prostate cancer	6.07e-05	0.000376	CcSEcCtD
Moclobemide—Nausea—Etoposide—prostate cancer	6.05e-05	0.000375	CcSEcCtD
Moclobemide—Hypertension—Epirubicin—prostate cancer	6.04e-05	0.000374	CcSEcCtD
Moclobemide—Feeling abnormal—Prednisone—prostate cancer	6.02e-05	0.000373	CcSEcCtD
Moclobemide—Ill-defined disorder—Doxorubicin—prostate cancer	6.01e-05	0.000372	CcSEcCtD
Moclobemide—Pruritus—Docetaxel—prostate cancer	5.99e-05	0.000371	CcSEcCtD
Moclobemide—Gastrointestinal pain—Prednisone—prostate cancer	5.97e-05	0.00037	CcSEcCtD
Moclobemide—Chest pain—Epirubicin—prostate cancer	5.96e-05	0.000369	CcSEcCtD
Moclobemide—Myalgia—Epirubicin—prostate cancer	5.96e-05	0.000369	CcSEcCtD
Moclobemide—Agitation—Doxorubicin—prostate cancer	5.95e-05	0.000368	CcSEcCtD
Moclobemide—Anxiety—Epirubicin—prostate cancer	5.94e-05	0.000368	CcSEcCtD
Moclobemide—Discomfort—Epirubicin—prostate cancer	5.88e-05	0.000364	CcSEcCtD
Moclobemide—Asthenia—Capecitabine—prostate cancer	5.88e-05	0.000364	CcSEcCtD
Moclobemide—Malaise—Doxorubicin—prostate cancer	5.84e-05	0.000361	CcSEcCtD
Moclobemide—Dry mouth—Epirubicin—prostate cancer	5.83e-05	0.000361	CcSEcCtD
Moclobemide—Syncope—Doxorubicin—prostate cancer	5.81e-05	0.000359	CcSEcCtD
Moclobemide—Urticaria—Prednisone—prostate cancer	5.8e-05	0.000359	CcSEcCtD
Moclobemide—Pruritus—Capecitabine—prostate cancer	5.8e-05	0.000359	CcSEcCtD
Moclobemide—Diarrhoea—Docetaxel—prostate cancer	5.79e-05	0.000359	CcSEcCtD
Moclobemide—Abdominal pain—Prednisone—prostate cancer	5.77e-05	0.000357	CcSEcCtD
Moclobemide—Confusional state—Epirubicin—prostate cancer	5.76e-05	0.000356	CcSEcCtD
Moclobemide—Palpitations—Doxorubicin—prostate cancer	5.72e-05	0.000354	CcSEcCtD
Moclobemide—Loss of consciousness—Doxorubicin—prostate cancer	5.69e-05	0.000352	CcSEcCtD
Moclobemide—Shock—Epirubicin—prostate cancer	5.62e-05	0.000348	CcSEcCtD
Moclobemide—Diarrhoea—Capecitabine—prostate cancer	5.61e-05	0.000347	CcSEcCtD
Moclobemide—Dizziness—Docetaxel—prostate cancer	5.6e-05	0.000347	CcSEcCtD
Moclobemide—Hypertension—Doxorubicin—prostate cancer	5.59e-05	0.000346	CcSEcCtD
Moclobemide—Tachycardia—Epirubicin—prostate cancer	5.57e-05	0.000345	CcSEcCtD
Moclobemide—Hyperhidrosis—Epirubicin—prostate cancer	5.52e-05	0.000342	CcSEcCtD
Moclobemide—Myalgia—Doxorubicin—prostate cancer	5.51e-05	0.000341	CcSEcCtD
Moclobemide—Chest pain—Doxorubicin—prostate cancer	5.51e-05	0.000341	CcSEcCtD
Moclobemide—Anxiety—Doxorubicin—prostate cancer	5.49e-05	0.00034	CcSEcCtD
Moclobemide—Discomfort—Doxorubicin—prostate cancer	5.45e-05	0.000337	CcSEcCtD
Moclobemide—Dizziness—Capecitabine—prostate cancer	5.42e-05	0.000336	CcSEcCtD
Moclobemide—Dry mouth—Doxorubicin—prostate cancer	5.39e-05	0.000334	CcSEcCtD
Moclobemide—Vomiting—Docetaxel—prostate cancer	5.38e-05	0.000333	CcSEcCtD
Moclobemide—Rash—Docetaxel—prostate cancer	5.34e-05	0.00033	CcSEcCtD
Moclobemide—Hypotension—Epirubicin—prostate cancer	5.34e-05	0.00033	CcSEcCtD
Moclobemide—Dermatitis—Docetaxel—prostate cancer	5.33e-05	0.00033	CcSEcCtD
Moclobemide—Confusional state—Doxorubicin—prostate cancer	5.33e-05	0.00033	CcSEcCtD
Moclobemide—Headache—Docetaxel—prostate cancer	5.3e-05	0.000328	CcSEcCtD
Moclobemide—Asthenia—Prednisone—prostate cancer	5.24e-05	0.000324	CcSEcCtD
Moclobemide—Vomiting—Capecitabine—prostate cancer	5.21e-05	0.000323	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.2e-05	0.000322	CcSEcCtD
Moclobemide—Shock—Doxorubicin—prostate cancer	5.2e-05	0.000322	CcSEcCtD
Moclobemide—Rash—Capecitabine—prostate cancer	5.17e-05	0.00032	CcSEcCtD
Moclobemide—Pruritus—Prednisone—prostate cancer	5.17e-05	0.00032	CcSEcCtD
Moclobemide—Insomnia—Epirubicin—prostate cancer	5.16e-05	0.00032	CcSEcCtD
Moclobemide—Dermatitis—Capecitabine—prostate cancer	5.16e-05	0.00032	CcSEcCtD
Moclobemide—Tachycardia—Doxorubicin—prostate cancer	5.16e-05	0.000319	CcSEcCtD
Moclobemide—Headache—Capecitabine—prostate cancer	5.13e-05	0.000318	CcSEcCtD
Moclobemide—Paraesthesia—Epirubicin—prostate cancer	5.13e-05	0.000317	CcSEcCtD
Moclobemide—Hyperhidrosis—Doxorubicin—prostate cancer	5.11e-05	0.000316	CcSEcCtD
Moclobemide—Dyspnoea—Epirubicin—prostate cancer	5.09e-05	0.000315	CcSEcCtD
Moclobemide—Somnolence—Epirubicin—prostate cancer	5.08e-05	0.000314	CcSEcCtD
Moclobemide—Nausea—Docetaxel—prostate cancer	5.03e-05	0.000311	CcSEcCtD
Moclobemide—Dyspepsia—Epirubicin—prostate cancer	5.03e-05	0.000311	CcSEcCtD
Moclobemide—Diarrhoea—Prednisone—prostate cancer	5e-05	0.000309	CcSEcCtD
Moclobemide—Decreased appetite—Epirubicin—prostate cancer	4.96e-05	0.000307	CcSEcCtD
Moclobemide—Hypotension—Doxorubicin—prostate cancer	4.94e-05	0.000306	CcSEcCtD
Moclobemide—Fatigue—Epirubicin—prostate cancer	4.92e-05	0.000305	CcSEcCtD
Moclobemide—Constipation—Epirubicin—prostate cancer	4.88e-05	0.000302	CcSEcCtD
Moclobemide—Nausea—Capecitabine—prostate cancer	4.87e-05	0.000301	CcSEcCtD
Moclobemide—Dizziness—Prednisone—prostate cancer	4.83e-05	0.000299	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.81e-05	0.000298	CcSEcCtD
Moclobemide—Insomnia—Doxorubicin—prostate cancer	4.78e-05	0.000296	CcSEcCtD
Moclobemide—Paraesthesia—Doxorubicin—prostate cancer	4.74e-05	0.000294	CcSEcCtD
Moclobemide—Dyspnoea—Doxorubicin—prostate cancer	4.71e-05	0.000292	CcSEcCtD
Moclobemide—Feeling abnormal—Epirubicin—prostate cancer	4.71e-05	0.000291	CcSEcCtD
Moclobemide—Somnolence—Doxorubicin—prostate cancer	4.7e-05	0.000291	CcSEcCtD
Moclobemide—Gastrointestinal pain—Epirubicin—prostate cancer	4.67e-05	0.000289	CcSEcCtD
Moclobemide—Dyspepsia—Doxorubicin—prostate cancer	4.65e-05	0.000288	CcSEcCtD
Moclobemide—Vomiting—Prednisone—prostate cancer	4.64e-05	0.000287	CcSEcCtD
Moclobemide—Rash—Prednisone—prostate cancer	4.6e-05	0.000285	CcSEcCtD
Moclobemide—Dermatitis—Prednisone—prostate cancer	4.6e-05	0.000285	CcSEcCtD
Moclobemide—Decreased appetite—Doxorubicin—prostate cancer	4.59e-05	0.000284	CcSEcCtD
Moclobemide—Headache—Prednisone—prostate cancer	4.57e-05	0.000283	CcSEcCtD
Moclobemide—Fatigue—Doxorubicin—prostate cancer	4.55e-05	0.000282	CcSEcCtD
Moclobemide—Urticaria—Epirubicin—prostate cancer	4.54e-05	0.000281	CcSEcCtD
Moclobemide—Constipation—Doxorubicin—prostate cancer	4.52e-05	0.00028	CcSEcCtD
Moclobemide—Abdominal pain—Epirubicin—prostate cancer	4.51e-05	0.000279	CcSEcCtD
Moclobemide—Feeling abnormal—Doxorubicin—prostate cancer	4.35e-05	0.00027	CcSEcCtD
Moclobemide—Nausea—Prednisone—prostate cancer	4.34e-05	0.000269	CcSEcCtD
Moclobemide—Gastrointestinal pain—Doxorubicin—prostate cancer	4.32e-05	0.000267	CcSEcCtD
Moclobemide—Urticaria—Doxorubicin—prostate cancer	4.2e-05	0.00026	CcSEcCtD
Moclobemide—Abdominal pain—Doxorubicin—prostate cancer	4.18e-05	0.000259	CcSEcCtD
Moclobemide—Asthenia—Epirubicin—prostate cancer	4.1e-05	0.000254	CcSEcCtD
Moclobemide—Pruritus—Epirubicin—prostate cancer	4.04e-05	0.00025	CcSEcCtD
Moclobemide—Diarrhoea—Epirubicin—prostate cancer	3.91e-05	0.000242	CcSEcCtD
Moclobemide—Asthenia—Doxorubicin—prostate cancer	3.79e-05	0.000235	CcSEcCtD
Moclobemide—Dizziness—Epirubicin—prostate cancer	3.78e-05	0.000234	CcSEcCtD
Moclobemide—Pruritus—Doxorubicin—prostate cancer	3.74e-05	0.000231	CcSEcCtD
Moclobemide—Vomiting—Epirubicin—prostate cancer	3.63e-05	0.000225	CcSEcCtD
Moclobemide—Diarrhoea—Doxorubicin—prostate cancer	3.61e-05	0.000224	CcSEcCtD
Moclobemide—Rash—Epirubicin—prostate cancer	3.6e-05	0.000223	CcSEcCtD
Moclobemide—Dermatitis—Epirubicin—prostate cancer	3.6e-05	0.000223	CcSEcCtD
Moclobemide—Headache—Epirubicin—prostate cancer	3.58e-05	0.000221	CcSEcCtD
Moclobemide—Dizziness—Doxorubicin—prostate cancer	3.49e-05	0.000216	CcSEcCtD
Moclobemide—Nausea—Epirubicin—prostate cancer	3.39e-05	0.00021	CcSEcCtD
Moclobemide—Vomiting—Doxorubicin—prostate cancer	3.36e-05	0.000208	CcSEcCtD
Moclobemide—Rash—Doxorubicin—prostate cancer	3.33e-05	0.000206	CcSEcCtD
Moclobemide—Dermatitis—Doxorubicin—prostate cancer	3.33e-05	0.000206	CcSEcCtD
Moclobemide—Headache—Doxorubicin—prostate cancer	3.31e-05	0.000205	CcSEcCtD
Moclobemide—Nausea—Doxorubicin—prostate cancer	3.14e-05	0.000194	CcSEcCtD
Moclobemide—CYP2D6—Metabolism—PLCB2—prostate cancer	6.89e-06	5.76e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LRP2—prostate cancer	6.89e-06	5.76e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2C18—prostate cancer	6.89e-06	5.76e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MED12—prostate cancer	6.85e-06	5.73e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.85e-06	5.73e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC22A3—prostate cancer	6.83e-06	5.71e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HSD3B1—prostate cancer	6.83e-06	5.71e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PLCB2—prostate cancer	6.83e-06	5.71e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LRP2—prostate cancer	6.83e-06	5.71e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2C18—prostate cancer	6.83e-06	5.71e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GNG5—prostate cancer	6.8e-06	5.69e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—P4HB—prostate cancer	6.76e-06	5.65e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—P4HB—prostate cancer	6.7e-06	5.6e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CAV1—prostate cancer	6.65e-06	5.56e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	6.63e-06	5.54e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC22A1—prostate cancer	6.57e-06	5.5e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TBXAS1—prostate cancer	6.55e-06	5.48e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA4—prostate cancer	6.55e-06	5.48e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NCOA3—prostate cancer	6.55e-06	5.48e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC22A1—prostate cancer	6.52e-06	5.45e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.44e-06	5.39e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.44e-06	5.38e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SULT2A1—prostate cancer	6.41e-06	5.36e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	6.4e-06	5.35e-05	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTEN—prostate cancer	6.39e-06	5.34e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA2—prostate cancer	6.38e-06	5.34e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SULT2A1—prostate cancer	6.35e-06	5.31e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCG5—prostate cancer	6.31e-06	5.27e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SULT1A1—prostate cancer	6.31e-06	5.27e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MED12—prostate cancer	6.3e-06	5.27e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GNG5—prostate cancer	6.25e-06	5.23e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MED12—prostate cancer	6.25e-06	5.23e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HPGDS—prostate cancer	6.25e-06	5.22e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GNG5—prostate cancer	6.2e-06	5.18e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA1—prostate cancer	6.16e-06	5.15e-05	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—EP300—prostate cancer	6.09e-06	5.1e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTO1—prostate cancer	6.09e-06	5.09e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HSD3B2—prostate cancer	6.09e-06	5.09e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NAT2—prostate cancer	6.09e-06	5.09e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ACHE—prostate cancer	6.06e-06	5.07e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTT1—prostate cancer	6.06e-06	5.07e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CG—prostate cancer	6.06e-06	5.06e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NCOA3—prostate cancer	6.02e-06	5.04e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2A6—prostate cancer	5.99e-06	5.01e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NCOA3—prostate cancer	5.97e-06	4.99e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.97e-06	4.99e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.87e-06	4.91e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.86e-06	4.9e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PLCB2—prostate cancer	5.84e-06	4.88e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2C18—prostate cancer	5.84e-06	4.88e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LRP2—prostate cancer	5.84e-06	4.88e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKR1C3—prostate cancer	5.83e-06	4.87e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PRKACB—prostate cancer	5.8e-06	4.85e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HPGDS—prostate cancer	5.75e-06	4.81e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP17A1—prostate cancer	5.74e-06	4.8e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—INS—prostate cancer	5.73e-06	4.79e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—P4HB—prostate cancer	5.73e-06	4.79e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2C19—prostate cancer	5.71e-06	4.78e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HPGDS—prostate cancer	5.7e-06	4.76e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2C19—prostate cancer	5.66e-06	4.73e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.66e-06	4.73e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CREBBP—prostate cancer	5.61e-06	4.69e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ACHE—prostate cancer	5.57e-06	4.66e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTT1—prostate cancer	5.57e-06	4.66e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC22A1—prostate cancer	5.57e-06	4.66e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTT1—prostate cancer	5.53e-06	4.62e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ACHE—prostate cancer	5.53e-06	4.62e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2A6—prostate cancer	5.51e-06	4.61e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.51e-06	4.6e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NCOA2—prostate cancer	5.47e-06	4.57e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2A6—prostate cancer	5.46e-06	4.57e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.44e-06	4.55e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SULT2A1—prostate cancer	5.43e-06	4.54e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKR1C3—prostate cancer	5.36e-06	4.48e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MED12—prostate cancer	5.34e-06	4.47e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PRKACB—prostate cancer	5.33e-06	4.46e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CD—prostate cancer	5.32e-06	4.45e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKR1C3—prostate cancer	5.31e-06	4.44e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GNG5—prostate cancer	5.3e-06	4.43e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PRKACB—prostate cancer	5.29e-06	4.42e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP17A1—prostate cancer	5.28e-06	4.41e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP17A1—prostate cancer	5.23e-06	4.37e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC5A5—prostate cancer	5.21e-06	4.36e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.16e-06	4.31e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NCOA3—prostate cancer	5.1e-06	4.27e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2E1—prostate cancer	5.09e-06	4.26e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NQO1—prostate cancer	5.04e-06	4.21e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NCOA2—prostate cancer	5.03e-06	4.2e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NOS3—prostate cancer	5.03e-06	4.2e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.01e-06	4.19e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NCOA2—prostate cancer	4.98e-06	4.17e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TH—prostate cancer	4.96e-06	4.15e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.93e-06	4.12e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP3A4—prostate cancer	4.91e-06	4.11e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.89e-06	4.09e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HPGDS—prostate cancer	4.87e-06	4.07e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2C19—prostate cancer	4.84e-06	4.05e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1B1—prostate cancer	4.83e-06	4.04e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC5A5—prostate cancer	4.8e-06	4.01e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC5A5—prostate cancer	4.75e-06	3.98e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTT1—prostate cancer	4.72e-06	3.95e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ACHE—prostate cancer	4.72e-06	3.95e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.68e-06	3.92e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GGT1—prostate cancer	4.68e-06	3.91e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2A6—prostate cancer	4.67e-06	3.9e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.65e-06	3.89e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2E1—prostate cancer	4.64e-06	3.88e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CB—prostate cancer	4.64e-06	3.88e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NQO1—prostate cancer	4.63e-06	3.87e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NCOA1—prostate cancer	4.61e-06	3.85e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—prostate cancer	4.6e-06	3.84e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NQO1—prostate cancer	4.59e-06	3.84e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TH—prostate cancer	4.57e-06	3.82e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKR1C3—prostate cancer	4.54e-06	3.8e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP19A1—prostate cancer	4.54e-06	3.8e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TH—prostate cancer	4.53e-06	3.78e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.52e-06	3.78e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PRKACB—prostate cancer	4.52e-06	3.78e-05	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CA—prostate cancer	4.51e-06	3.77e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.5e-06	3.76e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP3A4—prostate cancer	4.48e-06	3.74e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP17A1—prostate cancer	4.47e-06	3.74e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.46e-06	3.73e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.44e-06	3.71e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.41e-06	3.69e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1B1—prostate cancer	4.4e-06	3.68e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—RXRA—prostate cancer	4.38e-06	3.66e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GGT1—prostate cancer	4.3e-06	3.6e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GGT1—prostate cancer	4.26e-06	3.57e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.26e-06	3.56e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NCOA2—prostate cancer	4.26e-06	3.56e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NCOA1—prostate cancer	4.24e-06	3.54e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—COMT—prostate cancer	4.22e-06	3.53e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTP1—prostate cancer	4.2e-06	3.51e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NCOA1—prostate cancer	4.2e-06	3.51e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.18e-06	3.49e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP19A1—prostate cancer	4.14e-06	3.46e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ITPR1—prostate cancer	4.13e-06	3.46e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.06e-06	3.4e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC5A5—prostate cancer	4.06e-06	3.4e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—RXRA—prostate cancer	4.03e-06	3.37e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTEN—prostate cancer	4.01e-06	3.35e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—RXRA—prostate cancer	3.99e-06	3.34e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2E1—prostate cancer	3.97e-06	3.32e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NQO1—prostate cancer	3.92e-06	3.28e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TYMS—prostate cancer	3.91e-06	3.27e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.89e-06	3.25e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—COMT—prostate cancer	3.88e-06	3.25e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TH—prostate cancer	3.87e-06	3.23e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTP1—prostate cancer	3.86e-06	3.23e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTM1—prostate cancer	3.86e-06	3.23e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—COMT—prostate cancer	3.85e-06	3.22e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.84e-06	3.21e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTP1—prostate cancer	3.83e-06	3.2e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP3A4—prostate cancer	3.83e-06	3.2e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—EP300—prostate cancer	3.82e-06	3.2e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.81e-06	3.18e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ITPR1—prostate cancer	3.8e-06	3.18e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LPL—prostate cancer	3.79e-06	3.17e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ITPR1—prostate cancer	3.77e-06	3.15e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1B1—prostate cancer	3.76e-06	3.15e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.71e-06	3.1e-05	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKT1—prostate cancer	3.68e-06	3.08e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1A1—prostate cancer	3.66e-06	3.06e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GGT1—prostate cancer	3.64e-06	3.05e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ERCC2—prostate cancer	3.63e-06	3.03e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TYMS—prostate cancer	3.59e-06	3e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NCOA1—prostate cancer	3.59e-06	3e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TYMS—prostate cancer	3.56e-06	2.98e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTM1—prostate cancer	3.55e-06	2.97e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP19A1—prostate cancer	3.54e-06	2.96e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTM1—prostate cancer	3.52e-06	2.94e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LPL—prostate cancer	3.48e-06	2.91e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LPL—prostate cancer	3.45e-06	2.89e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—RXRA—prostate cancer	3.41e-06	2.85e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTHFR—prostate cancer	3.41e-06	2.85e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.37e-06	2.81e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARA—prostate cancer	3.35e-06	2.8e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ERCC2—prostate cancer	3.34e-06	2.79e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.34e-06	2.79e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.32e-06	2.78e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ERCC2—prostate cancer	3.31e-06	2.77e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—COMT—prostate cancer	3.29e-06	2.75e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTP1—prostate cancer	3.27e-06	2.74e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ITPR1—prostate cancer	3.22e-06	2.69e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.17e-06	2.65e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CAV1—prostate cancer	3.15e-06	2.63e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTHFR—prostate cancer	3.14e-06	2.62e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTHFR—prostate cancer	3.11e-06	2.6e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARA—prostate cancer	3.08e-06	2.57e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARA—prostate cancer	3.05e-06	2.55e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TYMS—prostate cancer	3.04e-06	2.54e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTM1—prostate cancer	3.01e-06	2.52e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.01e-06	2.51e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LPL—prostate cancer	2.95e-06	2.47e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CAV1—prostate cancer	2.89e-06	2.42e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CAV1—prostate cancer	2.87e-06	2.4e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.87e-06	2.4e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.85e-06	2.38e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CA—prostate cancer	2.83e-06	2.37e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ERCC2—prostate cancer	2.83e-06	2.36e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.74e-06	2.29e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—INS—prostate cancer	2.71e-06	2.27e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTHFR—prostate cancer	2.66e-06	2.22e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CREBBP—prostate cancer	2.66e-06	2.22e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.64e-06	2.2e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.61e-06	2.19e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARA—prostate cancer	2.61e-06	2.18e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.52e-06	2.11e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—INS—prostate cancer	2.5e-06	2.09e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—INS—prostate cancer	2.47e-06	2.07e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CAV1—prostate cancer	2.45e-06	2.05e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CREBBP—prostate cancer	2.44e-06	2.04e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CREBBP—prostate cancer	2.42e-06	2.03e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NOS3—prostate cancer	2.38e-06	1.99e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.34e-06	1.96e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.32e-06	1.94e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKT1—prostate cancer	2.31e-06	1.93e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.3e-06	1.92e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.23e-06	1.87e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.2e-06	1.84e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NOS3—prostate cancer	2.19e-06	1.83e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—prostate cancer	2.18e-06	1.82e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NOS3—prostate cancer	2.17e-06	1.81e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—INS—prostate cancer	2.11e-06	1.77e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CREBBP—prostate cancer	2.07e-06	1.73e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.02e-06	1.69e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CB—prostate cancer	2e-06	1.67e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—prostate cancer	2e-06	1.67e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—prostate cancer	1.98e-06	1.66e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.96e-06	1.64e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTEN—prostate cancer	1.9e-06	1.59e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NOS3—prostate cancer	1.85e-06	1.55e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—EP300—prostate cancer	1.81e-06	1.51e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTEN—prostate cancer	1.75e-06	1.46e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTEN—prostate cancer	1.73e-06	1.45e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.71e-06	1.43e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—prostate cancer	1.7e-06	1.42e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—EP300—prostate cancer	1.66e-06	1.39e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—EP300—prostate cancer	1.65e-06	1.38e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTEN—prostate cancer	1.48e-06	1.24e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—EP300—prostate cancer	1.41e-06	1.18e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.34e-06	1.12e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.23e-06	1.03e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.22e-06	1.02e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKT1—prostate cancer	1.09e-06	9.15e-06	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.04e-06	8.72e-06	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKT1—prostate cancer	1.01e-06	8.41e-06	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKT1—prostate cancer	9.97e-07	8.34e-06	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKT1—prostate cancer	8.52e-07	7.13e-06	CbGpPWpGaD
